EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gilbert Massard
Stefano Elia
Jean-Marie Wihlm
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massard, G.
Right arrow Articles by Wihlm, J.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massard, G.
Right arrow Articles by Wihlm, J.-M.

Eur J Cardiothorac Surg 1999;16:276-282
© 1999 Elsevier Science NL

Local control of disease and survival following bronchoplastic lobectomy for non-small cell lung cancer

Gilbert Massard, Romain Kessler, Bernard Gasser, Xavier Ducrocq, Stefano Elia, Stéphanie Gouzou, Jean-Marie Wihlm

Service de Chirurgie Thoracique and Institut de Pathologie, Hôpitaux Universitaires de Strasbourg, F-67091 Strasbourg, France

Corresponding author. Tel.: +33-3-88-11-62-02; fax: +33-3-88-11-60-77
e-mail: Gilbert.Massard{at}chru-strasbourg.fr

Background: This study was designed to determine whether bronchoplastic resection could be an alternative to pneumonectomy in patients with operable primary lung cancer. Methods: From 1980 to 1996, 63 patients (59 males and four females; mean age 62±7 years) underwent a bronchoplastic lobectomy for non-small cell lung cancer, indicated because of a disabled respiratory function in 34 patients, and performed electively in 29 patients. There were 38 right upper lobectomies, four bilobectomies, one middle lobectomy combined with lower lobe apical segmentectomy, ten left upper and ten left lower lobectomies. The bronchoplasty was a full sleeve in 24 patients, and a bronchial wedge resection in 39. Results: A single patient died post-operatively (1.6%). Specific procedure-related complications are summarized as follows: six anastomotic complications managed conservatively (9.5%), 15 space problems (23.8%), nine sputum retentions (14.2%). Pathologic staging classified 30 patients in stage I, 21 patients in stage II, and 12 in stage IIIA. Estimated 5-year survival was 69.7±9.8% in stage I, 37.1±12.1% in stage II, and 8.3±8.0% in stage IIIA. Fourteen patients (22.2%) developed locoregional recurrence. Three of them died with local recurrence alone, whereas 10 developed metastatic progression; a single patient is alive following completion pneumonectomy. According to stage, three recurrences occurred in stage I (10%), six in stage II (28%), and five in stage IIIA (38%). Actuarial freedom from local recurrence was significantly higher after elective procedures (P=0.019); there was a trend towards improved outcome following right-sided procedures (P=0.079) and following wedge bronchoplasty (P=0.055). Five patients experienced a second primary cancer (7.9%), which was resected in four. Conclusion: Bronchoplastic resections achieve local control and long-term survival comparable to standard resections in patients with stage I or II disease, and may be considered as a valuable alternative to pneumonectomy.

Key Words: Lung cancer • Sleeve lobectomy • Bronchoplasty • Survival • Recurrence




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. Milman, A. W. Kim, W. H. Warren, M. J. Liptay, C. Miller, S. Basu, and L. P. Faber
The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Ann. Thorac. Surg., September 1, 2009; 88(3): 945 - 950.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
C. Ludwig, P. Morand, J. Schnell, and E. Stoelben
Preserving Middle Lobe to Improve Lung Function in Non-Small-Cell Lung Cancer
Asian Cardiovasc Thorac Ann, April 1, 2009; 17(2): 153 - 156.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Rea, G. Marulli, M. Schiavon, A. Zuin, A.-M. Hamad, G. Rizzardi, E. Perissinotto, and F. Sartori
A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer
Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 488 - 492.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Lucchi, F. Melfi, A. Ribechini, P. Dini, L. Duranti, G. Fontanini, and A. Mussi
Sleeve and wedge parenchyma-sparing bronchial resections in low-grade neoplasms of the bronchial airway
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 373 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. Lemaitre, Z. Mansour, E. A. Kochetkova, C. Koriche, X. Ducrocq, J.-M. Wihlm, E. Quoix, and G. Massard
Bronchoplastic lobectomy: do early results depend on the underlying pathology? A comparison between typical carcinoids and primary lung cancer.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 168 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
C. Ludwig, E. Stoelben, M. Olschewski, and J. Hasse
Comparison of Morbidity, 30-Day Mortality, and Long-Term Survival After Pneumonectomy and Sleeve Lobectomy For Non-Small Cell Lung Carcinoma
Ann. Thorac. Surg., March 1, 2005; 79(3): 968 - 973.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J. Deslauriers, J. Gregoire, L. F. Jacques, M. Piraux, L. Guojin, and Y. Lacasse
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences
Ann. Thorac. Surg., April 1, 2004; 77(4): 1152 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
P. H. Hollaus, P. N. Wurnig, and N. S. Pridun
The natural history of recurrence after bronchoplastic procedures for non-small cell lung cancer
Ann. Thorac. Surg., August 1, 2003; 76(2): 363 - 369.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Chunwei, W. Weiji, Z. Xinguan, N. Qingzen, J. Xiangmin, and Z. Qingzhen
Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 209 - 213.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
E. Fadel, B. Yildizeli, A. R. Chapelier, I. Dicenta, S. Mussot, and P. G. Dartevelle
Sleeve lobectomy for bronchogenic cancers: factors affecting survival
Ann. Thorac. Surg., September 1, 2002; 74(3): 851 - 859.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. Mezzetti, T. Panigalli, L. Giuliani, F. Raveglia, F. Lo Giudice, and S. Meda
Personal experience in lung cancer sleeve lobectomy and sleeve pneumonectomy
Ann. Thorac. Surg., June 1, 2002; 73(6): 1736 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
A.E. Martin-Ucar, N. Chaudhuri, J.G. Edwards, and D.A. Waller
Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery
Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 601 - 605.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. Kotoulas, G. Lazopoulos, C. Foroulis, M. Konstantinou, P. Tomos, and A. Lioulias
Wedge resection of the bronchus: an alternative bronchoplastic technique for preservation of lung tissue
Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 679 - 683.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.